7 episodes
NECTA Annual Drug Development Meeting NECTA
-
- Health & Fitness
Each year the NSW Early Phase Clinical Trials Alliance (NECTA) hosts the international Drug Development Meeting. Join us in listening to world-renowned speakers dive into topics across oncological therapy development, from trial design to the emerging use of AI.
-
Precision Medicine - Have we reached a therapeutic plateau? 2024 and Beyond….
Speakers: Prof Anthony Joshua & Dr Rasha Cosman,
St Vincent’s Hospital Sydney
Session 3, Talk 3 -
Dose Ranging and Optimisation in Oncology: Implications for the Design and Conduct of Early Clinical Trials
Speaker: Prof Lesley Seymour, Queens University Kingston Ontario - Session 3, Talk 2
-
Artificial Intelligence (AI) and Big Data in clinical trials
Speaker: Dr Raanan Berger, Sheba Medical Center Hospital
Session 3, Talk 1 -
Myeloid cell headwinds for GD2-CAR-T cell therapy
Speaker: Prof Michael Brown, Royal Adelaide Hospital
Session 2, Talk 2 -
Developing tumour microenvironment CARs
Speaker: Prof Paul Neeson, Peter MacCallum Cancer Centre - Session 2, Talk 1
-
Findings from Australian oncology early career professionals
Dr Jenny Liu, St Vincent’s Hospital Sydney -
Benefits
of liquid biopsy with an early phase trial referral network
Dr
Abhijit Pal, Liverpool Hospital -
Informed
consent for early phase cancer clinical trials – common pitfalls and pragmatic solutions
Dr Christina Teng, Scientia Clinical Research - Case Study: the impact of trial participation on the individual patient
Session 1, Section 2